Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Interferon Induced with Helicase C Domain 1 (IFIH1) Peptide

IFIH1 Reactivity: Human, Rat Host: Synthetic BP
Catalog No. ABIN2710437
  • Target See all IFIH1 products
    IFIH1 (Interferon Induced with Helicase C Domain 1 (IFIH1))
    Origin
    Human, Rat
    Source
    • 7
    Synthetic
    Application
    Blocking Peptide (BP)
    Characteristics
    The peptide is used to block Anti-MDA5 Antibody reactivity.
  • Application Notes
    Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Storage
    -20 °C
    Storage Comment
    Shipped at 4°C. Store at -20°C for one year.
    Expiry Date
    12 months
  • Target
    IFIH1 (Interferon Induced with Helicase C Domain 1 (IFIH1))
    Synonyms
    MDA5 Peptide, Hlcd Peptide, IDDM19 Peptide, MDA-5 Peptide, RLR-2 Peptide, 9130009C22Rik Peptide, Helicard Peptide, RGD1560496 Peptide, interferon induced with helicase C domain 1 Peptide, IFIH1 Peptide, Ifih1 Peptide
    Background
    MDA5, RH116, Interferon-induced helicase C domain-containing protein 1, Clinically amyopathic dermatomyositis autoantigen 140 kDa, CADM-140 autoantigen, Helicase with 2 CARD domains, Helicard, Interferon-induced with helicase C domain protein 1, Melanoma differentiation-associated protein 5, MDA-5, Murabutide down-regulated protein, RIG-I-like receptor 2, RLR-2, RNA helicase-DEAD box protein 116
    Gene ID
    64135
    UniProt
    Q9BYX4
You are here:
Support